Happy New Year 2010

After the year 2009 has been that of recognition of the therapeutic benefit of Meveol by health authorities and European American who designated orphan drug, the year 2010 will be the establishment of early clinical trials which alone can we hope to confirm these promising results.

In this context we call upon all to contribute to the advancement of the program and its funding.

On behalf of the Cystic Fibrosis Association Innovation I offer my best wishes for 2010, it can give us reason to hope for significant advances in this common struggle we are waging against cystic fibrosis.

Translation Project